0000919574-20-006214.txt : 20201007 0000919574-20-006214.hdr.sgml : 20201007 20201007120306 ACCESSION NUMBER: 0000919574-20-006214 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20201007 DATE AS OF CHANGE: 20201007 EFFECTIVENESS DATE: 20201007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Euclidean Fund For Cancer Research LP CENTRAL INDEX KEY: 0001729236 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-311389 FILM NUMBER: 201228479 BUSINESS ADDRESS: STREET 1: EUCLIDEAN TECHNOLOGIES GP, LLC STREET 2: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-839-8586 MAIL ADDRESS: STREET 1: EUCLIDEAN TECHNOLOGIES GP, LLC STREET 2: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D/A 1 primary_doc.xml X0708 D/A LIVE 0001729236 Euclidean Fund For Cancer Research LP EUCLIDEAN TECHNOLOGIES GP, LLC 800 5TH AVENUE, SUITE 4100 SEATTLE WA WASHINGTON 98104 206-839-8586 DELAWARE None None Limited Partnership true 2018 -- Euclidean Technologies GP, LLC 800 5th Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Promoter General Partner -- Euclidean Technologies Management, LLC 800 5th Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Promoter Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06c 3C 3C.1 true 0000919574-19-006264 2018-05-01 true true true false 0 Indefinite 10424999 Indefinite false 8 0 0 0 true The Investment Manager receives customary management fees. true Euclidean Fund For Cancer Research LP /s/ John Alberg John Alberg Managing Member 2020-10-07